Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-03-04 @ 3:44 PM
Study NCT ID:
NCT04201418
Status:
COMPLETED
Last Update Posted:
2022-06-06
First Post:
2019-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation
Sponsor:
Alnylam Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-13
First Submit QC Date:
None
Study First Post Date:
2019-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-03
Last Update Post Date:
2022-06-06
Last Update Post Date Type:
ACTUAL